No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
50 – 80
Sex
Any
Study type
Observational
Participants needed
1,000 (estimated)
Sponsor
Temple University · Other
Who this trial is looking for
This trial is looking for people aged 50 to 80 who have been screened for early lung cancer using low dose CT imaging. Participants will help study how chronic obstructive pulmonary disease (COPD) is related to lung cancer screening.
Are You a Good Fit for This Trial?
You may be able to join if
I am between 50 and 80 years old
I have been screened for early lung cancer using low dose CT imaging
You may not be able to join if
I am under 50 years old
I am over 80 years old
I have not been screened for lung cancer
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Chronic obstructive pulmonary disease is highly prevalent globally, with considerable morbidity and mortality associated. In the US, it is the 4th leading cause of death, as well as contributing to significant costs on healthcare utilization including hospitalization. Population-based screening for COPD has not been recommended by the US Preventative Services Task Force (USPSTF). However, LDCT scr…
Chronic obstructive pulmonary disease is highly prevalent globally, with considerable morbidity and mortality associated. In the US, it is the 4th leading cause of death, as well as contributing to significant costs on healthcare utilization including hospitalization. Population-based screening for COPD has not been recommended by the US Preventative Services Task Force (USPSTF). However, LDCT screening for lung cancer in patients aged 50- 80 with ≥ 20 pack year smoking has been shown to improve survival. COPD is highly prevalent within LCS programs, with estimated rates of obstructive lung function of up to 59% and evidence of emphysema on CT scan in around 70%.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* 50 to 80 years old
* Screened for early lung cancer using low dose CT imaging
Exclusion Criteria:
* Under 50; over 80 years old
* No lung cancer screening
Inclusion Criteria:
* 50 to 80 years old
* Screened for early lung cancer using low dose CT imaging
Exclusion Criteria:
* Under 50; over 80 years old
* No lung cancer screening
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.